Arcadia Biosciences (RKDA) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • about 1 month agoArcadia Biosciences (RKDA) came out with a quarterly loss of $2.48 per share versus the Zacks Consensus Estimate of a loss of $2.68. This compares to loss of $6.31 per share a year ago. These figures...